Ionis Pharmaceuticals, Inc. (IONS) Social Stream



Ionis Pharmaceuticals, Inc. (IONS): $37.19

0.08 (+0.22%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Ionis Pharmaceuticals Inc (IONS) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Ionis Pharmaceuticals Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 13 $68 $20 $46.045 $36.48 26.22%
2021-12-07 13 $68 $20 $45.409 $36.48 24.48%
2021-12-08 13 $68 $22 $45.318 $36.48 24.23%
2021-12-28 13 $68 $22 $45.136 $36.48 23.73%
2022-01-21 13 $68 $22 $44.681 $36.48 22.48%
2022-02-24 13 $68 $22 $43.772 $36.48 19.99%
2022-02-28 13 $68 $22 $43.136 $36.48 18.25%
2022-03-01 15 $68 $22 $43.591 $36.48 19.49%
2022-03-07 14 $68 $22 $42.125 $36.48 15.47%
2022-03-24 13 $68 $22 $41.708 $36.48 14.33%

The Trend in the Analyst Price Target


Over the past 15 months, IONS's average price target has gone down $23.66.

IONS reports an average of 41.94% for its upside potential over the past 51 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-17 19 114 20 57.710 40.78 41.52%
2021-05-15 19 114 20 57.830 38.24 51.23%
2021-06-13 19 114 20 57.830 37.93 52.47%
2021-07-03 19 114 20 57.830 39.92 44.86%
2021-11-04 13 68 20 46.045 34.63 32.96%

IONS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.72 4 1 4 2 2 13

The Trend in the Broker Recommendations


IONS's average broker recommendation rating worsened by 0.26 over the prior 90 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for IONS as an investment opportunity.

  • IONS has a lower variance in analysts' estimates than -1020.01% of all US stocks.
  • In terms of how Ionis Pharmaceuticals Inc fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 121.83% of that group.
  • Ionis Pharmaceuticals Inc's number of analysts covering the stock is greater than 1069.77% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, Ionis Pharmaceuticals Inc's average analyst price target is higher than 274.18% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Ionis Pharmaceuticals Inc are HZNP, GSK, and GRFS.

Is IONS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6799 seconds.